CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Clinico-pathological profile and survival pattern in elderly patients with advanced non-small cell lung cancer (nslc)

Author: 
YumkhaibamSobita Devi, Dulasiraman Ponnas, S., Nithin Raj, D., Himadri Kumar Daru, Devandiran, R. S. and Laishram Jaichand Singh
Subject Area: 
Health Sciences
Abstract: 

Background: More than 50% of new cases of lung cancer are diagnosed in elderly patients. Does age is a factor for deciding the treatment options? The question remains unsolved even in present era as the median survival time of elderly patients was significantly lower compared with that of younger patients. Methods: We conducted a cross sectional study using data base of 175 patients of primary lung cancer with age 60 years and above diagnosed in indoor and outdoor of the Department of Radiotherapy at Regional Cancer Centre, RIMS, Manipur, India from January 2011 to December 2015. Results: The median age at diagnosis was 70years. There were 113 male (64.6%) patients and 62 female (35.4%) patients. The most common radiological presentation was mass (59.4%) followed by collapse-consolidation (22.8%) and pleural effusion (17.8%). Out of 175 patients, 51% of patients had squamous cell carcinoma, adenocarcinoma (33.7%), large cell carcinoma (9.1%) and undifferentiated carcinoma (6%). The median overall survival in patients underwent chemotherapy alone was found to be 17 months, in patients undergone concomitant chemo-radiation was 23 months , in patients underwent radiotherapy alone 16 months, patients underwent targeted therapy 14 months and patients who received best supportive care was 5 months. Conclusion: Our results allow us to conclude that elderly patients with good performance status are likely to benefit from radical treatments. Concurrent chemo-radiation seems to increase median survival even in elderly population with advanced stage disease.

PDF file: 

CALL FOR PAPERS

 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

CHUDE NKIRU PATRICIA
Nigeria
Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran